We are international
Donate
TEXT SIZE   


Phase 2 Study of Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (PX-171-003)
By Sundar Jagannath, M.D.
XIIth International Myeloma Workshop in Washington, DC
Sundar Jagannath, M.D.
St. Vincent's Cancer Center, New York, NY
02.23.09



XIIth International Myeloma Workshop in Washington, DC - On-Demand Only
Session: Clinical - New Agents
Chairs: Alok Sharma, M.D., Meletios Dimopoulos, M.D.

February 27, 2009, 14:00 - 14:15 Eastern Standard Time


Phase 2 Study of Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (PX-171-003)
Dr. Sundar Jagannath
St. Vincent's Cancer Center, New York, NY

 


Back to the Meeting Index


 related articles